In another study, Braig et al. (2014) demonstrated that telomerase-targeting strategy could alleviate the tumor promoting effect of BCR-ABL via inducing senescence in CML-like cells (33). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.